Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
PRICE
Prev Close
63.48
Open
63.49
Day Range63.44 – 63.50
63.44
63.50
52W Range42.11 – 63.50
42.11
63.50
100% of range
50-Day MA
63.48(+0.0%)
200-Day MA
54.91(+15.6%)
VOLUME & SIZE
Avg Volume
2.3M
FUNDAMENTALS
P/E Ratio
-27.8x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.22
Market-like
TECHNICAL
RSI (14)
74
Overbought
CTLT News
About
Catalent, Inc., an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey.